FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

398774004: Product containing aspirin and caffeine and dihydrocodeine tartrate (medicinal product)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1778277015 Aspirin + caffeine + dihydrocodeine bitartrate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3490606019 Product containing aspirin and caffeine and dihydrocodeine tartrate (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3494792010 Product containing aspirin and caffeine and dihydrocodeine tartrate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    4233211000005119 acetylsalicylsyre + caffein + dihydrocodeinbitartrat da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    acetylsalicylsyre + caffein + dihydrocodeinbitartrat Is a Product containing caffeine (medicinal product) false Inferred relationship Some
    acetylsalicylsyre + caffein + dihydrocodeinbitartrat Is a Product containing dihydrocodeine (medicinal product) false Inferred relationship Some
    acetylsalicylsyre + caffein + dihydrocodeinbitartrat Is a kombinationspræparat med acetylsalicylsyre false Inferred relationship Some
    acetylsalicylsyre + caffein + dihydrocodeinbitartrat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Xanthine false Inferred relationship Some
    acetylsalicylsyre + caffein + dihydrocodeinbitartrat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Dihydrocodeinbitartrat false Inferred relationship Some
    acetylsalicylsyre + caffein + dihydrocodeinbitartrat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Caffeine false Inferred relationship Some
    acetylsalicylsyre + caffein + dihydrocodeinbitartrat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Stimulant (substance) false Inferred relationship Some
    acetylsalicylsyre + caffein + dihydrocodeinbitartrat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Aspirin (substance) false Inferred relationship Some
    acetylsalicylsyre + caffein + dihydrocodeinbitartrat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Dihydrocodeine (substance) false Inferred relationship Some
    acetylsalicylsyre + caffein + dihydrocodeinbitartrat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bronchodilator (substance) false Inferred relationship Some
    acetylsalicylsyre + caffein + dihydrocodeinbitartrat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Opioid receptor agonist false Inferred relationship Some
    acetylsalicylsyre + caffein + dihydrocodeinbitartrat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Phosphodiesterase inhibitor false Inferred relationship Some
    acetylsalicylsyre + caffein + dihydrocodeinbitartrat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Xanthine false Inferred relationship Some
    acetylsalicylsyre + caffein + dihydrocodeinbitartrat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Dihydrocodeine tartrate false Inferred relationship Some
    acetylsalicylsyre + caffein + dihydrocodeinbitartrat Is a Product containing aspirin (medicinal product) false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) Is a False acetylsalicylsyre + caffein + dihydrocodeinbitartrat Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    GB English

    US English

    Back to Start